World's Best Scientists 2026 revealed!
Markku S. Nieminen

Markku S. Nieminen

D-Index & Metrics

Medicine

D-Index
129
Citations
114947
World Ranking
2520
National Ranking
28

Overview

Markku S. Nieminen is affiliated with the University of Helsinki in Finland. Their research primarily focuses on medicine, with a concentration in cardiology and related fields.

Their recent publications cover a variety of topics within cardiovascular medicine and pharmacology. Notable works include:

  • Lipoprotein(a) and Benefit of PCSK9 Inhibition in Patients With Nominally Controlled LDL Cholesterol (2021), Journal of the American College of Cardiology
  • Levosimendan Efficacy and Safety: 20 Years of SIMDAX in Clinical Use (2020), Journal of Cardiovascular Pharmacology
  • Levosimendan Efficacy and Safety: 20 years of SIMDAX in Clinical Use (2020), Cardiac Failure Review
  • Relation of Lipoprotein(a) Levels to Incident Type 2 Diabetes and Modification by Alirocumab Treatment (2021), Diabetes Care
  • Risk of sudden cardiac death associated with QRS, QTc, and JTc intervals in the general population (2022), Heart Rhythm

Their frequent co-authors indicate collaboration with established researchers in cardiovascular medicine, including:

  • Shaun G. Goodman
  • Gregory G. Schwartz
  • Michael Szarek
  • J. Wouter Jukema
  • Robert Pordy

Major publication venues reflect the scientist's focus and include:

  • Journal of the American College of Cardiology
  • Journal of Cardiovascular Pharmacology
  • Cardiac Failure Review
  • Diabetes Care
  • Heart Rhythm

Their work spans a range of subfields and topics within medicine, emphasizing cardiovascular health and related economic evaluations. Main fields of study are:

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Economics and Econometrics
  • Biomedical Engineering
  • Genetics

Main research topics include:

  • Lipoproteins and Cardiovascular Health
  • Health Systems, Economic Evaluations, Quality of Life
  • Heart Failure Treatment and Management
  • Cardiac Structural Anomalies and Repair
  • Mechanical Circulatory Support Devices
  • Pharmaceutical Economics and Policy
  • Cardiovascular Function and Risk Factors

The scientist's contributions reflect multidisciplinary approaches integrating clinical cardiology, pharmacology, and health economics, advancing understanding in cardiovascular function, treatments, and associated metabolic conditions.

Best Publications

  • Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Björn Dahlöf;Richard B Devereux;Sverre E Kjeldsen;Stevo Julius

  • ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: the Task Force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM).

    Kenneth Dickstein;Alain Cohen-Solal;Gerasimos Filippatos;John J V McMurray

  • Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial—Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial

    Peter S Sever;Björn Dahlöf;Neil R Poulter;Hans Wedel

  • Biological, clinical and population relevance of 95 loci for blood lipids

    Tanya M. Teslovich;Kiran Musunuru;Albert V. Smith;Andrew C. Edmondson

  • Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology.

    Karl Swedberg;John Cleland;Henry Dargie;Helmut Drexler

  • Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial

    Björn Dahlöf;Peter S Sever;Neil R Poulter;Hans Wedel

  • Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction.

    P Saikku;P Saikku;K Mattila;K Mattila;M.S Nieminen;M.S Nieminen;J.K Huttunen;J.K Huttunen

  • Plasma HDL cholesterol and risk of myocardial infarction: A mendelian randomisation study

    Benjamin F. Voight;Benjamin F. Voight;Benjamin F. Voight;Gina M. Peloso;Gina M. Peloso;Marju Orho-Melander;Ruth Frikke-Schmidt

  • A comprehensive 1000 Genomes–based genome-wide association meta-analysis of coronary artery disease

    M Nikpay;A Goel;Won H-H.;L M Hall

  • Hundreds of variants clustered in genomic loci and biological pathways affect human height

    Hana Lango Allen;Karol Estrada;Guillaume Lettre;Sonja I. Berndt

  • Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol.

    Lars H Lindholm;Hans Ibsen;Björn Dahlöf;Richard B Devereux

  • Large-scale association analysis identifies new risk loci for coronary artery disease

    Panos Deloukas;Stavroula Kanoni;Christina Willenborg;Martin Farrall

  • Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology.

    Markku S. Nieminen;Silvia G. Priori;Maria Angeles Alonso Garcia;Andrzej Budaj

  • EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population.

    Markku S. Nieminen;Dirk Brutsaert;Kenneth Dickstein;Helmut Drexler

  • Targeted Anticytokine Therapy in Patients with Chronic Heart Failure: Results of the Randomized Etanercept Worldwide Evaluation (RENEWAL)

    Douglas L. Mann;John J.V. McMurray;Milton Packer;Karl Swedberg

  • Effect of nesiritide in patients with acute decompensated heart failure.

    C. M. O'Connor;R. C. Starling;A. F. Hernandez;P. W. Armstrong

  • Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure: The SURVIVE Randomized Trial

    Alexandre Mebazaa;Markku S Nieminen;Milton Packer;Alain Cohen-Solal

  • Angiotensin II receptor blockade reduces new-onset atrial fibrillation and subsequent stroke compared to atenolol: The Losartan Intervention For End point reduction in hypertension (LIFE) study

    Kristian Wachtell;Mika Lehto;Eva Gerdts;Michael H. Olsen

  • Prognostic significance of left ventricular mass change during treatment of hypertension

    Richard B Devereux;Kristian Wachtell;Eva Gerdts;Krister K. Boman

  • A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease

    Majid Nikpay;Anuj Goel;Hong-Hee Won;Leanne M. Hall

Frequent Co-Authors

Richard B. Devereux
Richard B. Devereux Cornell University
Björn Dahlöf
Björn Dahlöf Sahlgrenska University Hospital
Kristian Wachtell
Kristian Wachtell Cornell University
Sverre E. Kjeldsen
Sverre E. Kjeldsen University of Oslo
Veikko Salomaa
Veikko Salomaa Finnish Institute for Health and Welfare
Markus Perola
Markus Perola Finnish Institute for Health and Welfare
Stevo Julius
Stevo Julius University of Michigan–Ann Arbor
Peter M. Okin
Peter M. Okin Cornell University
Hans Wedel
Hans Wedel University of Gothenburg

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re exploring medical studies in the USA, online degree programs offer flexible pathways to meet different career goals. Many students opt for accelerated dnp programs to quickly advance to leadership roles in nursing. These programs are designed for working nurses who want to obtain their Doctor of Nursing Practice in less time.

For those concerned about program difficulty, resources like easiest dnp program reddit can provide real-world insights and student experiences to help you choose the right fit. If you’re interested in a faster entry into nursing, consider 9 month lpn program options. These allow students to become Licensed Practical Nurses quickly—ideal for those seeking immediate, hands-on healthcare roles.

Specialized options are also available, such as psych nurse practitioner programs, which prepare graduates for advanced psychiatric care. Overall, online degrees and fast-track pathways can help streamline your journey in medicine, offering flexibility and career advancement suited to your goals.

Best Scientists Citing Markku S. Nieminen

Trending Scientists

Recently Published Articles